• nl

Carduso Capital Groningen invests in DEAM Holding BV.

DEAM is a young company co-based in Groningen that develops precision medical devices, specialising in steerable, minimally invasive instruments. The DEAM instruments are steerable in all directions, making it possible for surgeons to get an optimal operating position, also in areas that are not easy to reach or access. The DEAM steerable instruments offer great benefits in combination with the latest 3D-imaging technologies used during surgery.

DEAM has a strong R&D-collaboration with several departments and specialists of the University Medical Centre of Groningen (UMCG). These R&D programmes are focussing on minimal invasive interventions and therapies, such as: reduced incision laparoscopic surgery; Neurology, intervention Cardiology and heart tissue monitoring by a steerable biopsy tool.

For more information on DEAM Holding: www.deamcorporation.com

The Carduso investment makes it possible for DEAM to start-up their production phase for their first applications, focussing on a market introduction by the end of this year.

Groningen, May 12, 2017

For further information:

DEAM Holding:
Dhr. Wimold Peters​​
Tel: +31 (0) 6-53338054
Email: wpsp@deamcorporation.com

Carduso Capital: 
Dhr. Frits Kok
Tel: +31 (0) 6-53751211
Mail: frits.kok@cardusocapital.com

Carduso Capital invests in “Gum Irrigator”

“Due to the social impact on patients and cost savings, the Gum Irrigator fits perfectly with Carduso’s regional and technical objectives,” said Frits Kok on behalf of the fund. Sophie van Dijk, Co-Founder and CEO of the Gum Irrigator, adds: “After an extensive testing phase we are excited to be able to roll out our technology in the market with Carduso’s participation. Our first target markets are the Netherlands and its surrounding countries, however, Europe and North-America will be our eventual focus.”

Co-founder and CSO, dr.Johan van Dijk, periodontist and implantologist emphasizes the importance of the Gum Irrigator and the impact of healthy gums on the body. “Gum diseases could not only cause loss of teeth but could also lead to other serious diseases; heart diseases, long infections, premature births and could lead to the worsening of existing diabetes. Furthermore, the infection enzymes (CRP) caused by periodontitis, could strengthen other infections in our bodies and weaken the overall immune system of the body.

The Gum Irrigator has an unique method of subgingival cleaning of the biofilm with its interplay between vacuum and fluid applied to the pockets around the natural teeth or implants. This is a non-invasive, pain free method which enhances the recovery of inflamed gums.

The Carduso Capital finance will accelerate the company’s market entrance. The technique is finalized and well-functioning prototypes have been extensively used in a clinical study over a number of years. The Gum Irrigator is now ready to enter the production phase and by mid 2018, the first devices will be available to the professional dental market. Although the Gum Irrigator is firstly aimed at the professional dental market, there is a large opportunity for the consumer market. Due to its easiness of use and the fact that it is non-invasive and pain-free, the apparatus is perfect for home usage.

Groningen based Dr. Johan van Dijk invented the Gum Irrigator. He taught for many years at the Dental School of the University in Groningen, set up the first independent periodontal clinic in the Netherlands and is the author of many scientific national and international articles and of 2 books in the field of periodontology. Due to his unique knowledge of both theory and practice, the company does not only have a groundbreaking technology but also an advanced method of application. He acts as a medical-technical adviser. Co-founder, CEO Sophie van Dijk will continue to lead the commercialization of the Gum Irrigator with her successful and extensive international experience and knowledge in regards to new business development. For more info on Gum Irrigator: www.gum.care

Carduso Capital is an investment fund based in Groningen that participates in innovative technology companies with strong technological connections with the University of Groningen (RUG) and the University Medical Center Groningen (UMCG) and knowledge institutions within its network. Carduso Capital finds it important to invest in innovative companies that are in the early stage or at some point find funding to continue growing. Carduso Capital supports initiatives within the themes Life Sciences energy and sustainability on the basis of long term cooperation. In addition to financing offers also Carduso Capital management support and the possibility to use a wide international network. Investors in Carduso are: EIF, Investeringsfonds Groningen, NOM, De Friesland Participaties and RUG/UMCG.

Placement of the Gum Irrigator on the gums; pain-free and non-invasive

For more info on Carduso Capital: www.cardusocapital.com

Further information:

Gum Irrigator: 
Mevr. Sophie van Dijk
Tel: +31 (0) 6-22896796
Mail: sophie.vandijk@gum.care

Carduso Capital: 
Dhr. Frits Kok
Tel: +31 (0) 6-53751211
Mail: frits.kok@cardusocapital.com

Read More

Pieter Imhof appointed Chief Executive Officer BioBTX B.V.

On behalf of the shareholders, Cor Kamminga explains: “With the appointment of Pieter Imhof, we strengthen both the technical and commercial nature of BioBTX B.V., which will give us greater appeal to industrial partners to realize our growth strategy. Pieter brings a lot of experience in both the chemical and the energy sector and has a lot of experience in shaping strategic partnerships. ” Pieter Imhof (Netherlands, 1962) has held various management positions over a 16 years period at AkzoNobel Catalysts (later Albemarle Catalysts) in R&D, product & market development as well as Technical Service. In these roles he has successfully developed and commercialized several catalysts, catalysts components and additives worldwide.

After Albemarle Mr. Imhof has been responsible for business development and strategic account management in the Catalysis contract research and systems business unit of Avantium Chemicals BV, in the period in which Avantium grew from startup to a leading chemical technology company. Mr. Imhof holds a Ph.D. degree in chemistry after studies in chemistry, business economics and strategy.

About BioBTX B.V.

BioBTX B.V. is a Dutch company that converts biobased materials into chemical intermediates (aromatics and bio-oil) on the basis of its own proprietary catalytic pyrolysis technology. BTX represents Benzene, Toluene and Xylene. These chemicals typically originate from crude oil and can amongst others be used as building blocks for plastics. By application of the BioBTX technology a substantial contribution will be made to the sustainable production of plastics and many other chemical products. The University of Groningen is the scientific partner of BioBTX B.V.

For further information:

Mr. Pieter Imhof
Tel: +31 (0) 6-5152 1179
Mail: pieter.imhof@biobtx.nl

On behalf of the shareholders:
Dhr. Cor Kamminga
Tel: +31 (0) 6-4702 0103
Mail: k.j.kamminga@biobtx.nl

Read More